LEVELS – A Whole New Level cover image

#282 - Longevity biomarkers for healthy aging and well-being | Dr. Matt Kaeberlein & Mike Haney

LEVELS – A Whole New Level

00:00

Rapamycin Risk–Reward and Off‑Label Use Considerations

Matt reviews limited human safety data, common mouth sores, anecdotal benefits, and the need for more clinical trials.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app